Vitamin D Receptor TaqI Gene Variant in Exon 9 and Polycystic Ovary Syndrome Risk

Background: Polycystic ovary syndrome (PCOS) is known as a metabolic disorder. The results of recent studies implied that vitamin D receptor (VDR) genetic variants may impact PCOS and insulin resistance in women with PCOS. The aim of the present study was to determine the VDR TaqI gene variant i...

Full description

Bibliographic Details
Main Authors: Morteza Bagheri, Isa Abdi Rad, Nima Hosseini Jazani, Fariba Nanbakhsh
Format: Article
Language:English
Published: Royan Institute (ACECR), Tehran 2013-07-01
Series:International Journal of Fertility and Sterility
Subjects:
Online Access:http://www.ijfs.ir/article_45180_d41d8cd98f00b204e9800998ecf8427e.pdf
_version_ 1818267233445478400
author Morteza Bagheri
Isa Abdi Rad
Nima Hosseini Jazani
Fariba Nanbakhsh
author_facet Morteza Bagheri
Isa Abdi Rad
Nima Hosseini Jazani
Fariba Nanbakhsh
author_sort Morteza Bagheri
collection DOAJ
description Background: Polycystic ovary syndrome (PCOS) is known as a metabolic disorder. The results of recent studies implied that vitamin D receptor (VDR) genetic variants may impact PCOS and insulin resistance in women with PCOS. The aim of the present study was to determine the VDR TaqI gene variant in exon 9 (T/C) (rs731236) in normal controls and patients with PCOS for the first time in Iranian Azeri women. Materials and Methods: In this case control study between April 2011 and June 2012, a total of 76 women aged 18-40 years (38 patients with PCOS and 38 healthy women as normal controls) participated. Genotypes of VDR TaqI in exon 9 (T/C) (rs731236) were determined using the PCR-RFLP method. Results: The frequencies of VDR TaqI T anc C alleles were 0.605 and 0.395 in cases and 0.697 and 0.303 in controls. Also, the genotypic frequencies of VDR TaqI were 16) (42.11), 14(36.84), and 8(21.05) in cases, and 17(44.74), 19(50), and 2(5.26) in controls for TT, TC and CC genotypes respectively. There was no difference in genotype and allele frequencies between PCOS and controls (p value>0.05) with the exception of the CC genotype (p value=0.04). Conclusion: This report, a first of its own kind in Iranian Azeri patients, suggests that the CC genotype of VDR TaqI in exon 9 (rs731236) is associated with PCOS.
first_indexed 2024-12-12T20:19:20Z
format Article
id doaj.art-b317617efffe4aa4b9aad2e8ff3a8db0
institution Directory Open Access Journal
issn 2008-076X
2008-0778
language English
last_indexed 2024-12-12T20:19:20Z
publishDate 2013-07-01
publisher Royan Institute (ACECR), Tehran
record_format Article
series International Journal of Fertility and Sterility
spelling doaj.art-b317617efffe4aa4b9aad2e8ff3a8db02022-12-22T00:13:18ZengRoyan Institute (ACECR), TehranInternational Journal of Fertility and Sterility2008-076X2008-07782013-07-017211612145180Vitamin D Receptor TaqI Gene Variant in Exon 9 and Polycystic Ovary Syndrome RiskMorteza Bagheri0Isa Abdi Rad1Nima Hosseini Jazani2Fariba Nanbakhsh3Food and Beverages Safety Research Center, Urmia University of Medical Sciences, Urmia, Iran;Department of Genetics, Urmia University of Medical Sciences, Urmia, Iran;Cellular and Molecular Research Center, Urmia University of MedDepartment of Genetics, Urmia University of Medical Sciences, Urmia, Iran;Cellular and Molecular Research Center, Urmia University of Medical Sciences, Urmia, IranFood and Beverages Safety Research Center, Urmia University of Medical Sciences, Urmia, Iran;Cellular and Molecular Research Center, Urmia University of Medical Sciences, Urmia, Iran4Reproductive Health Research Center, Department of Obstetrics and Gynecology, Urmia University of Medical Sciences, Urmia, IranBackground: Polycystic ovary syndrome (PCOS) is known as a metabolic disorder. The results of recent studies implied that vitamin D receptor (VDR) genetic variants may impact PCOS and insulin resistance in women with PCOS. The aim of the present study was to determine the VDR TaqI gene variant in exon 9 (T/C) (rs731236) in normal controls and patients with PCOS for the first time in Iranian Azeri women. Materials and Methods: In this case control study between April 2011 and June 2012, a total of 76 women aged 18-40 years (38 patients with PCOS and 38 healthy women as normal controls) participated. Genotypes of VDR TaqI in exon 9 (T/C) (rs731236) were determined using the PCR-RFLP method. Results: The frequencies of VDR TaqI T anc C alleles were 0.605 and 0.395 in cases and 0.697 and 0.303 in controls. Also, the genotypic frequencies of VDR TaqI were 16) (42.11), 14(36.84), and 8(21.05) in cases, and 17(44.74), 19(50), and 2(5.26) in controls for TT, TC and CC genotypes respectively. There was no difference in genotype and allele frequencies between PCOS and controls (p value>0.05) with the exception of the CC genotype (p value=0.04). Conclusion: This report, a first of its own kind in Iranian Azeri patients, suggests that the CC genotype of VDR TaqI in exon 9 (rs731236) is associated with PCOS.http://www.ijfs.ir/article_45180_d41d8cd98f00b204e9800998ecf8427e.pdfvitamin d receptorpolycystic ovary syndromegenetic variation
spellingShingle Morteza Bagheri
Isa Abdi Rad
Nima Hosseini Jazani
Fariba Nanbakhsh
Vitamin D Receptor TaqI Gene Variant in Exon 9 and Polycystic Ovary Syndrome Risk
International Journal of Fertility and Sterility
vitamin d receptor
polycystic ovary syndrome
genetic variation
title Vitamin D Receptor TaqI Gene Variant in Exon 9 and Polycystic Ovary Syndrome Risk
title_full Vitamin D Receptor TaqI Gene Variant in Exon 9 and Polycystic Ovary Syndrome Risk
title_fullStr Vitamin D Receptor TaqI Gene Variant in Exon 9 and Polycystic Ovary Syndrome Risk
title_full_unstemmed Vitamin D Receptor TaqI Gene Variant in Exon 9 and Polycystic Ovary Syndrome Risk
title_short Vitamin D Receptor TaqI Gene Variant in Exon 9 and Polycystic Ovary Syndrome Risk
title_sort vitamin d receptor taqi gene variant in exon 9 and polycystic ovary syndrome risk
topic vitamin d receptor
polycystic ovary syndrome
genetic variation
url http://www.ijfs.ir/article_45180_d41d8cd98f00b204e9800998ecf8427e.pdf
work_keys_str_mv AT mortezabagheri vitamindreceptortaqigenevariantinexon9andpolycysticovarysyndromerisk
AT isaabdirad vitamindreceptortaqigenevariantinexon9andpolycysticovarysyndromerisk
AT nimahosseinijazani vitamindreceptortaqigenevariantinexon9andpolycysticovarysyndromerisk
AT faribananbakhsh vitamindreceptortaqigenevariantinexon9andpolycysticovarysyndromerisk